
USA - NYSE:APHA -
The current stock price of APHA is 15.38 null. In the past month the price decreased by -15.12%. In the past year, price increased by 353.69%.
Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada.
Aphria Inc
98 TALBOT STREET W.
LEAMINGTON A6 N8H 1M8
CEO: Irwin Simon
Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada.
The current stock price of APHA is 15.38 null. The price decreased by -0.45% in the last trading session.
APHA does not pay a dividend.
APHA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Aphria Inc (APHA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.35).
Aphria Inc (APHA) has a market capitalization of 4.87B null. This makes APHA a Mid Cap stock.
ChartMill assigns a technical rating of 5 / 10 to APHA. When comparing the yearly performance of all stocks, APHA is one of the better performing stocks in the market, outperforming 96.64% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to APHA. APHA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months APHA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 45.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -98.29% | ||
| ROA | -20.56% | ||
| ROE | N/A | ||
| Debt/Equity | 0.15 |